Diabetes, Obesity and Metabolism, 2026 Integrated Plasma Proteomics and Functional Analyses Reveal Hepatic
CDHR2
as a Potential Therapeutic Target in
MASLD Shi Y., Huang Q., Liu Y. et al. Olink Explore 3072/384Metabolic DiseasesHepatologyPathophysiologyPlasma | | | | |
Cancer Research, 2026 Ribonuclease 5/Angiogenin Suppresses Intestinal Tumor Initiation by Maintaining Crypt Homeostasis Shi X., Chen J., Bai R. et al. Olink Explore 3072/384OncologyCross-platform ValidationPlasma | | | | |
Journal of Allergy and Clinical Immunology, 2026 Human retinoic acid–inducible gene I (RIG-I) deficiency associated with susceptibility to classic Kaposi sarcoma Roussel L., Bernier S., Langelier M. et al. Olink Target 96OncologyInfectious DiseasesPathophysiologyCell Culture Supernatant | | | | |
Scientific Reports, 2026 Genetic predisposition to coffee consumption and the association with the early risk of atherosclerosis Qiao X., Toma V., Wang J. et al. Olink Target 96Olink Explore 3072/384CVDPathophysiologyPlasma | | | | |
Journal of Lipid Research, 2026 Low serum sphingosine-1-phospate and its chaperone ApoM associate with retinopathy of prematurity Nilsson A., Sjöbom U., Panwar M. et al. Olink Target 96OphthalmologyObstericsPathophysiologySerum | | | | |
European Journal of Medical Research, 2026 Integrating inflammation-oriented brain injury mechanisms in acute COVID-19 using multi-modality MRI and serum proteomics: a longitudinal study Lizhu Y., Sun J., Ao F. et al. Olink Target 96Infectious DiseasesPathophysiologyPlasma | | | | |
Frontiers in Cardiovascular Medicine, 2026 Combined diagnostic value of NT-proBNP, DLK-1, PSP-D and PCSK-9 in heart failure with preserved ejection fraction: a prospective biomarker study Xiaobin L., Yu Q., Jingjie F. et al. Olink Target 96CVDPatient StratificationSerum | | | | |
Bioengineering, 2026 Machine-Learning-Based Targeted Plasma Proteomic Analysis for Predicting Motor Progression in Parkinson’s Disease: An Interpretable Approach to Personalized Disease Management Lin W., Grewal S. Olink Target 96NeurologyPatient StratificationPlasma | | | | |
CHEST, 2026 Matrix Metalloproteinase 12 Improves the Differentiation of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis and Associates With Antigen Response Pathways Konkol S., Huang Y., Ma S. et al. Olink Explore 3072/384Respiratory DiseasesPatient StratificationPlasma | | | | |
International Journal of Molecular Sciences, 2026 Modeled Aqueous Humor Protein Concentrations to Enable Biomarker Development in Uveal Melanoma Huang E., Chen Y., Peng C. et al. Olink Explore 3072/384Olink Target 48OncologyOphthalmologyPatient StratificationAqueous Humor | | | | |
Nature Communications, 2026 Macrophage Gsα promotes NLRP3 stability and its intervention attenuates abdominal aortic aneurysm in male mice He L., Qin X., Ren Q. et al. Olink Target 48 MouseCVDPathophysiologyMouse Tissue Lysate | | | | |
Journal of Allergy and Clinical Immunology: Global, 2026 Impact of gut microbiome, plasma metabolites, peripheral immune cells, and circulating inflammatory protein on chronic spontaneous urticaria: Bidirectional 2-sample Mendelian randomization study and mediation analysis Deng L., Yao Y., Wang Q. et al. Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologyPlasma | | | | |
European Journal of Preventive Cardiology, 2026 Association between IL-6 and hs-CRP and cardiovascular risk in clinically relevant subgroups Bundgaard J., Ahlberg G., Rand S. et al. Olink Explore 3072/384CVDPatient StratificationPlasma | | | | |
Neuron, 2026 Large-scale CSF and plasma proteomics reveal immune, synaptic, and extracellular matrix disruptions across neurodegenerative diseases Ali M., Timsina J., Xu Y. et al. Olink Explore HTNeurologyCross-platform ValidationCSF | | | | |
npj Science of Food, 2026 Adherence to the EAT-Lancet Diet and Risk of Sepsis: A Prospective Cohort Study from the UK Biobank Nan W., Huang Q., He B. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesNutritional SciencePathophysiologyPlasma | | | | |
Acta Pharmaceutica Sinica B, 2026 Derivatization-enhanced thiol redox atlas reveals ENO1–SLC7A11 axis as Ferroptosis protector in myocardial injury Ma C., Lin M., Qiao Z. et al. Olink Explore 3072/384CVDPathophysiologyPlasma | | | | |
Neurology Neuroimmunology & Neuroinflammation, 2026 CSF Proteins Associated With Neuroaxonal Damage in Early Active Multiple Sclerosis Luessi F., Starvaggi Cucuzza C., Engel S. et al. Olink Target 96Olink Explore 3072/384NeurologyPathophysiologySerumCSF | | | | |
European Journal of Pharmacology, 2026 Integrative Mendelian randomization and experimental validation unveil novel druggable targets in primary biliary cholangitis Li Y., Xie H., Zhuang Z. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Signal Transduction and Targeted Therapy, 2026 Acyl-CoA-binding protein (ACBP): a poor-prognosis biomarker in sepsis and a target for disease mitigation Lambertucci F., Motiño O., Nogueira-Recalde U. et al. Olink Target 48 MouseImmunological & Inflammatory DiseasesPathophysiologyMouse Plasma | | | | |
Brain, 2026 Clinical and biochemical characterization of amyotrophic lateral sclerosis in a CHCHD10 R15L family Kwan J., Lantz C., Korobeynikov V. et al. Olink Explore HTNeurologyPathophysiologyCSF | | | | |